tirzepatide vs semaglutide cardiovascular glp #tizepatide #semaglutide #naturemedicine #aha25 Real-World Cardiovascular Outcomes of Obesity

First-time AOM semaglutide prescribing increased by over 50%, marking the largest quarter-over-quarter increase in first-time AOM semaglutide prescribing since mid-2024, likely driven by the approval of the oral formulation of Wegovy in December 2025

[16] It originates from the basal layer of the epidermis

Certain peptides support your body's natural growth hormone production, which plays a big role in daily energy

PlexusDx patients who prepare their digestive system early often experience smoother transitions to higher doses

Muayad J, Ahmed M, Malik A

Urva, et al., LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept, 2022, Cell Metabolism 34, 12341247